购物车
  • TargetMol
    您的购物车当前为空
前往下单页继续购物
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • VEGFR
    (2)
  • c-Kit
    (2)
  • c-RET
    (2)
  • Tyrosine Kinases
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 6-8周
    (1)
  • 8-10周
    (1)
TargetMol | Tags 通过 研究领域 筛选
  • 癌症研究
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "sim 010603"的结果。
筛选
搜索结果
TargetMol产品目录中 "

sim 010603

"的结果。
  • 抑制剂&激动剂
    3
    抑制剂&激动剂
  • SIM010603
    T715761032265-67-0
    SIM010603 is a structurally novel, oral, multi-targeted receptor tyrosine kinase inhibitor. SIM010603 inhibited stem cell factor receptor (Kit), vascular endothelial growth factor receptor-2 (VEGFR-2), platelet-derived growth factor receptor-β (PDGFR-β), glial cell line-derived neurotrophic factor receptor (Rearranged during Transfection; RET), and Fms-like tyrosine kinase-3 (FLT3) with IC(50) values between 5.0 and 68.1 nmol/l. SIM010603 inhibited the phosphorylation of PDGFR-β and VEGFR-2. Moreover, SIM010603 inhibited endothelial cell proliferation, endothelial cells chemotaxis, and corneal angiogenesis.
    c-Kitc-RETOthersVEGFR
    • ¥ 12800
    8-10周
    规格
    数量
  • Tafetinib
    SIM-010603, SIM010603, SIM 010603
    T289111032265-57-8In house
    Tafetinib (SIM-010603) 是一种新型有效且可口服的酪氨酸激酶抑制剂，具有抗血管生成和抗肿瘤活性。
    c-Kitc-RETTyrosine KinasesVEGFR
    • ¥ 1750
    现货
    规格
    数量
  • Dioxifedrine
    T7157510329-60-9
    Dioxifedrine is a beta-2 -adrenergic agonist with bronchodilator activity.
    Others
    6-8周
    询价